Caroline M Mitchell1, Sujatha Srinivasan, Xiang Zhan, Michael C Wu, Susan D Reed, Katherine A Guthrie, Andrea Z LaCroix, Tina Fiedler, Matthew Munch, Congzhou Liu, Noah G Hoffman, Ian A Blair, Katherine Newton, Ellen W Freeman, Hadine Joffe, Lee Cohen, David N Fredricks. 1. 1Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA 2Fred Hutchinson Cancer Research Center, Seattle, WA 3Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 4Department of Family Medicine and Public Health, University of California at San Diego, La Jolla, CA 5Department of Laboratory Medicine, University of Washington, Seattle, WA 6Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 7Group Health Research Institute, Seattle, WA 8Department of Obstetrics & Gynecology and Psychiatry, University of Pennsylvania, Philadelphia, PA 9Brigham and Women's Hospital and Dana Farber Cancer Center, Boston, MA 10Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
Abstract
OBJECTIVE: To examine associations between the composition of the vaginal microbiota and genitourinary menopausal symptoms, serum estrogen, and vaginal glycogen. METHODS: For this cross-sectional study, 88 women aged 40 to 62 years, enrolled in a hot flash treatment trial, provided vaginal swabs and a blood sample at enrollment. Bacterial communities were characterized using 16S rRNA PCR and deep sequencing targeting the V3-V4 region. Quantities of Lactobacillus crispatus and Lactobacillus iners were measured using qPCR. Self-reported genitourinary symptoms included: presence and severity of individual symptoms and identification of most bothersome symptom. Glycogen was measured fluorometrically in swab eluate. Serum estradiol (E2) and estrone (E1) were measured by liquid chromatography/mass spectrometry. Associations between bacteria, symptoms, glycogen, and serum estrogens were tested by linear regression or Wilcoxon signed-rank test, adjusted for multiple comparisons. Comparisons between groups used Kruskall-Wallis or Fisher's exact test. RESULTS: Of the 88 women, 33 (38%) had a majority of Lactobacillus species, whereas 58 (66%) had any Lactobacillus detected. Over half (53%) reported at least one vulvovaginal symptom (most commonly dryness), but symptoms were not associated with the presence of Lactobacillus species. Women with Lactobacillus-dominant communities had higher unconjugated serum estrone, but no difference in vaginal glycogen levels, compared with those with non-Lactobacillus-dominant communities. Higher serum E2 and E1 were not associated with either higher vaginal glycogen or detection of individual genera. CONCLUSIONS: Presence of Lactobacillus-dominant vaginal microbiota was not associated with fewer vulvovaginal symptoms. Serum estrone was higher in women with Lactobacillus dominance, but vaginal-free glycogen was not associated with composition of the vaginal microbiota.
OBJECTIVE: To examine associations between the composition of the vaginal microbiota and genitourinary menopausal symptoms, serum estrogen, and vaginal glycogen. METHODS: For this cross-sectional study, 88 women aged 40 to 62 years, enrolled in a hot flash treatment trial, provided vaginal swabs and a blood sample at enrollment. Bacterial communities were characterized using 16S rRNA PCR and deep sequencing targeting the V3-V4 region. Quantities of Lactobacillus crispatus and Lactobacillus iners were measured using qPCR. Self-reported genitourinary symptoms included: presence and severity of individual symptoms and identification of most bothersome symptom. Glycogen was measured fluorometrically in swab eluate. Serum estradiol (E2) and estrone (E1) were measured by liquid chromatography/mass spectrometry. Associations between bacteria, symptoms, glycogen, and serum estrogens were tested by linear regression or Wilcoxon signed-rank test, adjusted for multiple comparisons. Comparisons between groups used Kruskall-Wallis or Fisher's exact test. RESULTS: Of the 88 women, 33 (38%) had a majority of Lactobacillus species, whereas 58 (66%) had any Lactobacillus detected. Over half (53%) reported at least one vulvovaginal symptom (most commonly dryness), but symptoms were not associated with the presence of Lactobacillus species. Women with Lactobacillus-dominant communities had higher unconjugated serum estrone, but no difference in vaginal glycogen levels, compared with those with non-Lactobacillus-dominant communities. Higher serum E2 and E1 were not associated with either higher vaginal glycogen or detection of individual genera. CONCLUSIONS: Presence of Lactobacillus-dominant vaginal microbiota was not associated with fewer vulvovaginal symptoms. Serum estrone was higher in women with Lactobacillus dominance, but vaginal-free glycogen was not associated with composition of the vaginal microbiota.
Authors: J R Hilditch; J Lewis; A Peter; B van Maris; A Ross; E Franssen; G H Guyatt; P G Norton; E Dunn Journal: Maturitas Date: 1996-07 Impact factor: 4.342
Authors: Sujatha Srinivasan; Congzhou Liu; Caroline M Mitchell; Tina L Fiedler; Katherine K Thomas; Kathy J Agnew; Jeanne M Marrazzo; David N Fredricks Journal: PLoS One Date: 2010-04-15 Impact factor: 3.240
Authors: Rani Menon; Sara E Watson; Laura N Thomas; Clinton D Allred; Alan Dabney; M Andrea Azcarate-Peril; Joseph M Sturino Journal: Appl Environ Microbiol Date: 2013-07-19 Impact factor: 4.792
Authors: Gregory T Spear; Audrey L French; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Thomas H Sullivan; William W Spear; Alan Landay; Sandra Micci; Byung-Hoo Lee; Bruce R Hamaker Journal: J Infect Dis Date: 2014-04-15 Impact factor: 5.226
Authors: Catherine L Haggerty; Patricia A Totten; Gong Tang; Sabina G Astete; Michael J Ferris; Johana Norori; Debra C Bass; David H Martin; Brandie D Taylor; Roberta B Ness Journal: Sex Transm Infect Date: 2016-01-29 Impact factor: 3.519
Authors: Paria Mirmonsef; Anna L Hotton; Douglas Gilbert; Casey J Gioia; Danijela Maric; Thomas J Hope; Alan L Landay; Gregory T Spear Journal: PLoS One Date: 2016-04-19 Impact factor: 3.240
Authors: Caroline M Mitchell; Sujatha Srinivasan; Anna Plantinga; Michael C Wu; Susan D Reed; Katherine A Guthrie; Andrea Z LaCroix; Tina Fiedler; Matthew Munch; Congzhou Liu; Noah G Hoffman; Ian A Blair; Katherine Newton; Ellen W Freeman; Hadine Joffe; Lee Cohen; David N Fredricks Journal: Menopause Date: 2018-05 Impact factor: 2.953
Authors: Susan D Reed; Andrea Z LaCroix; Garnet L Anderson; Kristine E Ensrud; Bette Caan; Janet S Carpenter; Lee Cohen; Susan J Diem; Ellen W Freeman; Hadine Joffe; Joseph C Larson; Susan M McCurry; Caroline M Mitchell; Katherine M Newton; Barbara Sternfeld; Katherine A Guthrie Journal: Menopause Date: 2020-04 Impact factor: 2.953
Authors: Marie E Thoma; Rebecca M Brotman; Ronald H Gray; Nelson K Sewankambo; Maria J Wawer Journal: Sex Transm Infect Date: 2019-10-10 Impact factor: 3.519
Authors: Caroline M Mitchell; Nanxun Ma; Alissa J Mitchell; Michael C Wu; D J Valint; Sean Proll; Susan D Reed; Katherine A Guthrie; Andrea Z Lacroix; Joseph C Larson; Robert Pepin; Daniel Raftery; David N Fredricks; Sujatha Srinivasan Journal: Am J Obstet Gynecol Date: 2021-03-04 Impact factor: 10.693
Authors: Patricia L Hudson; Wodan Ling; Michael C Wu; Matthew R Hayward; Alissa J Mitchell; Joseph Larson; Katherine A Guthrie; Susan D Reed; Douglas S Kwon; Caroline M Mitchell Journal: J Infect Dis Date: 2021-12-01 Impact factor: 5.226
Authors: Madeline E Graham; William G Herbert; Stephanie D Song; Harshini N Raman; Jade E Zhu; Paulina E Gonzalez; Marina R S Walther-António; Marc J Tetel Journal: Trends Endocrinol Metab Date: 2021-05-25 Impact factor: 10.586